What are the Risks10 Dec 2020 19:54
1. The tests don't work? But they do. No question re BAMS and ELISA. Risk that the company is lying to us in the first para of the 23 Nov lfd RNS = Nil. Risk that LFD in clinical trials with our nose friendly swab does not beat the naso pharyngeal horrors = also virtually Nil surely.
2.We can't produce enough? Nice problem to have.
3.There is a further delay of up to a few months before we go commercial? On purpose framed this way as a suggested worst case scenario. Really, What would be the issue?
4. LFD (unlike BAMS and ELISA) is not "best in class"? Unlikely but possible scenario. We'd still make lots of Dosh and as Meat Loaf sang...…….
So lets cut to the chase less of the lazy thinking. What on earth do you mean those of you who say that compared to the average AIM share this one is risky?